Prenatal manifestation and management of a mother and child affected by spondyloperipheral dysplasia with a C-propeptide mutation in COL2A1: case report
- PMID: 21356074
- PMCID: PMC3058019
- DOI: 10.1186/1750-1172-6-7
Prenatal manifestation and management of a mother and child affected by spondyloperipheral dysplasia with a C-propeptide mutation in COL2A1: case report
Abstract
It is not unusual for patients with "rare" conditions, such as skeletal dysplasias, to remain undiagnosed until adulthood. In such cases, a pregnancy may unexpectedly reveal hidden problems and special needs. A 28 year old primigravida was referred to us at 17 weeks for counselling with an undiagnosed skeletal dysplasia with specific skeletal anomalies suggesting the collagen 2 disorder, spondyloperipheral dysplasia (SPD; MIM 156550).She was counselled about the probability of dominant inheritance and was offered a prenatal diagnosis by sonography. US examination at 17, 18 and 20 weeks revealed fetal macrocephaly, a narrow thorax, and shortening and bowing of long bones. The parents elected to continue the pregnancy. At birth the baby showed severe respiratory distress for four weeks which then resolved. Mutation analysis of both mother and child revealed a hitherto undescribed heterozygous nonsense mutation in the C-propeptide coding region of COL2A1 confirming the diagnosis of SPD while reinforcing the genotype-phenotype correlations between C-propeptide COL2A1 mutations and the SPD-Torrance spectrum. This case demonstrates the importance of a correct diagnosis even in adulthood, enabling individuals affected by rare conditions to be made aware about recurrence and pregnancy-associated risks, and potential complications in the newborn.
Figures







Similar articles
-
Spondyloperipheral dysplasia is caused by truncating mutations in the C-propeptide of COL2A1.Am J Med Genet A. 2004 Aug 30;129A(2):144-8. doi: 10.1002/ajmg.a.30222. Am J Med Genet A. 2004. PMID: 15316962
-
Dominant negative mutations in the C-propeptide of COL2A1 cause platyspondylic lethal skeletal dysplasia, torrance type, and define a novel subfamily within the type 2 collagenopathies.Am J Med Genet A. 2005 Feb 15;133A(1):61-7. doi: 10.1002/ajmg.a.30531. Am J Med Genet A. 2005. PMID: 15643621
-
Spondyloperipheral dysplasia as the mosaic form of platyspondylic lethal skeletal dyplasia torrance type in mother and fetus with the same COL2A1 mutation.Am J Med Genet A. 2012 Aug;158A(8):1948-52. doi: 10.1002/ajmg.a.35301. Epub 2012 Apr 11. Am J Med Genet A. 2012. PMID: 22495950
-
Mutation Update for COL2A1 Gene Variants Associated with Type II Collagenopathies.Hum Mutat. 2016 Jan;37(1):7-15. doi: 10.1002/humu.22915. Epub 2015 Oct 21. Hum Mutat. 2016. PMID: 26443184 Review.
-
Survival to adulthood and dominant inheritance of platyspondylic skeletal dysplasia, Torrance-Luton type.Pediatr Radiol. 2003 Nov;33(11):786-90. doi: 10.1007/s00247-003-1055-x. Epub 2003 Sep 5. Pediatr Radiol. 2003. PMID: 12961049 Review.
Cited by
-
Short stature, platyspondyly, hip dysplasia, and retinal detachment: an atypical type II collagenopathy caused by a novel mutation in the C-propeptide region of COL2A1: a case report.BMC Med Genet. 2016 Dec 12;17(1):96. doi: 10.1186/s12881-016-0357-4. BMC Med Genet. 2016. PMID: 27955642 Free PMC article.
-
Familial Aggregation of a Novel Missense Variant of COL2A1 Gene Associated with Short Extremities: Case Report and Review of the Literature.Children (Basel). 2022 Aug 14;9(8):1229. doi: 10.3390/children9081229. Children (Basel). 2022. PMID: 36010119 Free PMC article.
-
Endoplasmic reticulum stress in chondrodysplasias caused by mutations in collagen types II and X.Cell Stress Chaperones. 2016 Nov;21(6):943-958. doi: 10.1007/s12192-016-0719-z. Epub 2016 Aug 15. Cell Stress Chaperones. 2016. PMID: 27523816 Free PMC article. Review.
References
-
- Spranger J, Winterpacht A, Zabel B. The type II collagenopathies: a spectrum of chondrodysplasias. Eur J Pediatr. 1994;153:56–65. - PubMed
-
- Kelly TE, Lichtenstein JR, Dorst JP. An unusual familial spondyloepiphyseal dysplasia: 'spondyloperipheral dysplasia'. BDOAS. 1977;13(3B):149–165. - PubMed
-
- Sorge G, Ruggieri M, Lachman RS. Spondyloperipheral dysplasia. Am J Med Genet. 1995;59:139–142. - PubMed
-
- Zabel B, Hilbert K, Stoss H, Superti-Furga A, Spranger J, Winterpacht A. A specific collagen type II gene (COL2A1) mutation presenting as spondyloperipheral dysplasia. Am J Med Genet. 1996;63:123–128. - PubMed
-
- Zankl A, Zabel B, Hilbert K, Wildhardt G, Cuenot S, Xavier B, Ha-Winh R, Bonafé L, Spranger J, Superti-Furga A. Spondyloperipheral dysplasia is caused by truncating mutations in the C-propeptide of COL2A1. Am J Med Genet. 2004;129A:144–148. - PubMed
Publication types
MeSH terms
Substances
Supplementary concepts
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical